CD8+ T cells of Listeria monocytogenes-infected mice recognize both linear and spliced proteasome products

European Journal of Immunology

Volumn 46, Issue 5, 2016, Pages 1109-1118

  Platteel, Anouk C M ^a   Mishto, Michele ^b,c   Textoris Taube, Kathrin ^b   Keller, Christin ^b   Liepe, Juliane ^d   Busch, Dirk H ^e   Kloetzel, Peter M ^b   Sijts, Alice J A M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

CD8+ T cells; Listeria monocytogenes; MHC class I antigen processing; Proteasome; Proteasome catalyzed peptide splicing

Indexed keywords

PROTEASOME; EPITOPE; HLA ANTIGEN CLASS 1; PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; LISTERIOSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN QUATERNARY STRUCTURE; ANIMAL; ANTIGEN PRESENTATION; CHEMISTRY; COMPUTER SIMULATION; IMMUNE EVASION; IMMUNOLOGY; LISTERIA MONOCYTOGENES; METABOLISM; PROTEIN SPLICING;

ANIMALS; ANTIGEN PRESENTATION; CD8-POSITIVE T-LYMPHOCYTES; COMPUTER SIMULATION; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNE EVASION; LISTERIA MONOCYTOGENES; LISTERIOSIS; MASS SPECTROMETRY; MICE; PEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN SPLICING;

EID: 84960969183     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201545989     Document Type: Article

References (48)

1. Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D. et al., Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 1994. 78: 761-771.
2. Sijts, E. J. A. M. and Kloetzel, P. M., The role of the proteasome in the generation of MHC class I ligands and immune responses. Cell. Mol. Life Sci. 2011. 68: 1491-1502.
3. Cascio, P., Hilton, C., Kisselev, A. F., Rock, K. L. and Goldberg, A. L., 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. EMBO J. 2001. 20: 2357-2366.
4. Aki, M., Shimbara, N., Takashina, M., Akiyama, K., Kagawa, S., Tamura, T., Tanahashi, N. et al., Interferon-γ induces different subunit organizations and functional diversity of proteasomes. J. Biochem. 1994. 115: 257-269.
5. Dalet, A., Robbins, P. F., Stroobant, V., Vigneron, N., Li, Y. F., El-Gamil, M., Hanada, K. et al., An antigenic peptide produced by reverse splicing and double asparagine deamidation. Proc. Natl. Acad. Sci. USA 2011. 108: E323-E331.
6. Hanada, K., Yewdell, J. W. and Yang, J. C., Immune recognition of a human renal cancer antigen through post-translational protein splicing. Nature 2004. 427: 252-256.
7. Michaux, A., Larrieu, P., Stroobant, V., Fonteneau, J., Jotereau, F., Van Den Eynde, B. J., Moreau-Aubry, A. et al., A spliced antigenic peptide comprising a single spliced amino acid is produced in the proteasome by reverse splicing of a longer peptide fragment followed by trimming. J. Immunol. 2014. 192: 1962-1971.
8. Warren, E. H., Vigneron, N. J., Gavin, M. A., Coulie, P. G., Stroobant, V., Dalet, A., Tykodi, S. S. et al., An antigen produced by splicing of noncontiguous peptides in the reverse order. Science 2006. 313: 1444-1447.
9. Vigneron, N., Stroobant, V., Chapiro, J., Ooms, A., Degiovanni, G., Morel, S., Van Der Bruggen, P. et al., An antigenic peptide produced by peptide splicing in the proteasome. Science 2004. 304: 587-590.
10. Mishto, M., Goede, A., Taube, K. T., Keller, C., Janek, K., Henklein, P., Niewienda, A. et al., Driving forces of proteasome-catalyzed peptide splicing in yeast and humans. Mol. Cell. Proteomics 2012. 11: 1008-1023.
11. Dalet, A., Stroobant, V., Vigneron, N. and Van Den Eynde, B. J., Differences in the production of spliced antigenic peptides by the standard proteasome and the immunoproteasome. Eur. J. Immunol. 2011. 41: 39-46.
12. Vigneron, N. and Van den Eynde, B. J., Proteasome subtypes and the processing of tumor antigens: increasing antigenic diversity. Curr. Opin. Immunol. 2012. 24: 84-91.
13. Kincaid, E. Z., Che, J. W., York, I., Escobar, H., Reyes-Vargas, E., Delgado, J. C., Welsh, R. M. et al., Mice completely lacking immunoproteasomes show major changes in antigen presentation. Nat. Immunol. 2012. 13: 129-135.
14. Sijts, A. J. A. M., Ruppert, T., Rehermann, B., Schmidt, M., Koszinowski, U. and Kloetzel, P. M., Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes. J. Exp. Med. 2000. 191: 503-513.
15. Mishto, M., Liepe, J., Textoris-Taube, K., Keller, C., Henklein, P., Weberruß, M., Dahlmann, B. et al., Proteasome isoforms exhibit only quantitative differences in cleavage and epitope generation. Eur. J. Immunol. 2014. 44: 3508-3521.
16. Zanker, D. and Chen, W., Standard and immunoproteasomes show similar peptide degradation specificities. Eur. J. Immunol. 2014. 44: 3500-3503.
17. Mishto, M., Bellavista, E., Ligorio, C., Textoris-Taube, K., Santoro, A., Giordano, M., D'Alfonso, S. et al., Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in italian female population. PLoS One 2010. 5: e9287.
18. Liepe, J., Holzhütter, H. G., Bellavista, E., Kloetzel, P. M., Stumpf, M. P. H. and Mishto, M., Quantitative time-resolved analysis reveals intricate, differential regulation of standard- and immuno-proteasomes. eLife 2015. 4: e07545 2015.
19. Rammensee, H., Protein surgery. Nature 2004. 427: 203-204.
20. Berkers, C. R., de Jong, A., Ovaa, H. and Rodenko, B., Transpeptidation and reverse proteolysis and their consequences for immunity. Int. J. Biochem. Cell Biol. 2009. 41: 66-71.
21. Liepe, J., Mishto, M., Textoris-Taube, K., Janek, K., Keller, C., Henklein, P., Kloetzel, P. M. et al., The 20S proteasome splicing activity discovered by SpliceMet. PLoS Comput. Biol. 2010. 6: e1000830.
22. Textoris-Taube, K., Keller, C., Liepe, J., Henklein, P., Sidney, J., Sette, A., Kloetzel, P. et al., The T210M substitution in the HLA-A*02:01 gp100 epitope strongly affects overall proteasomal cleavage site usage and antigen processing. J. Biol. Chem. 2015. 290: 30417-30428.
23. Geginat, G., Schenk, S., Skoberne, M., Goebel, W. and Hof, H., A novel approach of direct ex vivo epitope mapping identifies dominant and subdominant CD4 and CD8 T cell epitopes from Listeria monocytogenes. J. Immunol. 2001. 166: 1877-1884.
24. Strehl, B., Joeris, T., Rieger, M., Visekruna, A., Textoris-Taube, K., Kaufmann, S. H. E., Kloetzel, P. M. et al., Immunoproteasomes are essential for clearance of Listeria monocytogenes in nonlymphoid tissues but not for induction of bacteria-specific CD8+ T cells. J. Immunol. 2006. 177: 6238-6244.
25. Deol, P., Zaiss, D. M. W., Monaco, J. J. and Sijts, A. J. A. M., Rates of processing determine the immunogenicity of immunoproteasome- generated epitopes. J. Immunol. 2007. 178: 7557-7562.
26. Zaiss, D. M. W., Bekker, C. P. J., Gröne, A., Lie, B. A. and Sijts, A. J. A. M., Proteasome immunosubunits protect against the development of CD8 T cell-mediated autoimmune diseases. J. Immunol. 2011. 187: 2302-2309.
27. De Verteuil, D., Muratore-Schroeder, T. L., Granados, D. P., Fortier, M., Hardy, M., Bramoullé, A., Caron, É. et al., Deletion of immunoproteasome subunits imprints on the transcriptome and has a broad impact on peptides presented by major histocompatibility complex I molecules. Mol. Cell. Proteomics 2010. 9: 2034-2047.
28. Chen, W., Norbury, C. C., Cho, Y., Yewdell, J. W. and Bennink, J. R., Immunoproteasomes shape immunodominance hierarchies of antiviral CD8+ T cells at the levels of T cell repertoire and presentation of viral antigens. J. Exp. Med. 2001. 193: 1319-1326.
29. Basler, M., Moebius, J., Elenich, L., Groettrup, M. and Monaco, J. J., An altered T cell repertoire in MECL-1-deficient mice. J. Immunol. 2006. 176: 6665-6672.
30. Chapiro, J., Claverol, S., Piette, F., Ma, W., Stroobant, V., Guillaume, B., Gairin, J. E. et al., Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation. J. Immunol. 2006. 176: 1053-1061.
31. Busch, D. H., Pilip, I. M., Vijh, S. and Pamer, E. G., Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity 1998. 8: 353-362.
32. Yewdell, J. W., Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. Immunity 2006. 25: 533-543.
33. Berkers, C. R., De Jong, A., Schuurman, K. G., Linnemann, C., Meiring, H. D., Janssen, L., Neefjes, J. J. et al., Definition of proteasomal peptide splicing rules for high-efficiency spliced peptide presentation by MHC class I molecules. J. Immunol. 2015. 195: 4085-4095.
34. Villanueva, M. S., Fischer, P., Feen, K. and Pamer, E. G., Efficiency of MHC class I antigen processing: a quantitative analysis. Immunity 1994. 1: 479-489.
35. Villanueva, M. S., Sijts, A. J. A. M. and Pamer, E. G., Listeriolysin is processed efficiently into an MHC class I-associated epitope in Listeria monocytogenes-infected cells. J. Immunol. 1995. 155: 5227-5233.
36. Pamer, E. G., Sijts, A. J. A. M., Villanueva, M. S., Busch, D. H. and Vijh, S., MHC class I antigen processing of Listeria monocytogenes proteins: implications for dominant and subdominant CTL responses. Immunol. Rev. 1997. 158: 129-136.
37. Mason, D., A very high level of crossreactivity is an essential feature of the T- cell receptor. Immunol. Today 1998. 19: 395-404.
38. Ossendorp, F., Eggers, M., Neisig, A., Ruppert, T., Groettrup, M., Sijts, A., Mengedé, E. et al., A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity 1996. 5: 115-124.
39. Tenzer, S., Wee, E., Burgevin, A., Stewart-Jones, G., Friis, L., Lamberth, K., Chang, C. H. et al., Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance. Nat. Immunol. 2009. 10: 636-646.
40. Beekman, N. J., Van Veelen, P. A., Van Hall, T., Neisig, A., Sijts, A., Camps, M., Kloetzel, P. M. et al., Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site. J. Immunol. 2000. 164: 1898-1905.
41. Textoris-Taube, K., Henklein, P., Pollmann, S., Bergann, T., Weisshoff, H., Seifert, U., Drung, I. et al., The N-terminal flanking region of the TRP2360-368 melanoma antigen determines proteasome activator PA28 requirement for epitope liberation. J. Biol. Chem. 2007. 282: 12749-12754.
42. Van Kaert, L., Ashton-Rickardt, P. G., Eichelberger, M., Gaczynska, M., Nagashima, K., Rock, K. L., Goldberg, A. L. et al., Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1994. 1: 533-541.
43. Fehling, H. J., Swat, W., Laplace, C., Kühn, R., Rajewsky, K., Müller, U. and Von Boehmer, H., MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 1994. 265: 1234-1237.
44. Gohlke, S., Mishto, M., Textoris-Taube, K., Keller, C., Giannin, C., Vasuri, F., Capizzi, E. et al., Molecular alterations in proteasomes of rat liver during aging result in altered proteolytic activities. Age 2014. 36: 57-72.
45. Mishto, M., Raza, M. L., de Biase, D., Ravizza, T., Vasuri, F., Martucci, M., Keller, C. et al., The immunoproteasome ß5i subunit is a key contributor to ictogenesis in a rat model of chronic epilepsy. Brain Behav. Immun. 2015. 49: 188-196.
46. Saric, T., Chang, S., Hattori, A., York, I. A., Markant, S., Rock, K. L., Tsujimoto, M. et al., An IFN-γ-induced aminopeptidase in the ER, ERAP I, trims precursors to MHC class I-presented peptides. Nat. Immunol. 2002. 3: 1169-1176.
47. Mishto, M., Santoro, A., Bellavista, E., Sessions, R., Textoris-Taube, K., Dal Piaz, F., Carrard, G. et al., A structural model of 20S immunoproteasomes: effect of LMP2 codon 60 polymorphism on expression, activity, intracellular localisation and insight into the regulatory mechanisms. Biol. Chem. 2006. 387: 417-429.
48. Peters, B. and Sette, A., Integrating epitope data into the emerging web of biomedical knowledge resources. Nat. Rev. Immunol. 2007. 7: 485-490.